Theory of porous electrodes—XII. The negative plate of the lead-acid battery

Partial differential equations describing the transport of mass and electricity in the pores of the negative electrode of a lead-acid battery were derived. The theory is based on exact transport equations and on the assumption that the electrode potential is governed by the Nernst equation. Volume changes in both phases are taken into account. Numerical solutions depend on the product of electrode thickness times current density and on the initial porosity. Differences between the negative and positive plates are discussed.     

Curing of epoxy resins with amines

Summary Using determination of the critical molar ratio of functional groups necessary for gel formation with amino groups in excess, network formation was investigated in the reaction of diglycidyl ether of Bisphenol A (DGEBA) and nitrogen-containing epoxy resins — diglycidylaniline and N,N,N,N-tetraglycidyl-4,4-diaminodiphenylmethane with aromatic or aliphatic amines. It was found that in the case of nitrogen-containing epoxides the crosslinking is accompanied by pronounced cyclization, unlike in systems with DGEBA. Gelation depends on the relative reactivity of the primary and secondary hydrogen atom of the amino group. In the case of nitrogen-containing polyepoxides, the dependence of reactivities of adjacent glycidyl groups is also operative.     

A comparative study of a fluidised bed reactor and a gas lift loop reactor for the IBE process: Part I. Reactor design and scale down approach

For the continuous production of isopropanol-butanol mixtures by immobilised Clostridium spp. (the IBE process) two reactor types were studied: a fluidised bed reactor with liquid recycling (FBR) and an external loop gas lift reactor (GLR). A large scale design (50–65 m³) was made for both reactors. A regime analysis, by evaluating the time constants for e.g. mixing and conversion, identified the ruling regime. Via the scale down approach two representative model reactors were developed: a 10 dm³ FBR reactor (H/D=25, D=0.08 m) and a 15 dm³ external loop GLR (H/D = 12.5, D_r=D_d=0.08 m). For both reactors the hydrodynamical behaviour and the total reactor performance were studied and are described in parts II and III of this study.     

Molecular cytogenetics: applications in clinical genetics

Epidural neuroblastoma xenografts in nude rats causing paraparesis were treated with intravenous injection of an anti-GD2 monoclonal antibody 3F8. Metastatic or primary epidural tumors in humans cause rapid neurologic compromise. Treatment is often unsatisfactory. An animal model was established to study antibody targeted therapy of epidural tumor. Human neuroblastoma was xenotransplanted into the thoracic epidural space of nude rats. When paraparesis developed, animals were treated intravenously with an anti-GD2 monoclonal antibody, 3F8, either alone or radiolabeled with 131Iodine. Improvement in neurologic function occurred in 2 of 20 (10%) animals receiving no treatment or control antibody, 14 of 17 (82%) animals receiving 3F8 alone and all 9 animals receiving 131I-3F8 (p < 0.0001 for 3F8 or 131I-3F8 vs. control). Six animals treated with 3F8 alone recovered normal neurologic function and remained well until sacrifice 10 days later. Four animals treated with 3F8 alone had no tumor evident on pathologic examination. The percent injected dose of 131I-3F8/g tumor in 5 samples ranged from 0.73% to 3.8%. These observations demonstrate that neoplastic epidural compression of the spinal cord in the rat can be treated successfully with intravenous unmodified monoclonal antibody and that signs of neurologic dysfunction can be reversed. The potential of this approach in treating patients with epidural tumors and other neoplasms, especially those that are not sensitive to chemotherapy or radiotherapy, deserves to be explored.     

Matrix-assisted laser desorption/ionization mass spectrometry of proteins extracted directly from sodium dodecyl sulphate-polyacrylamide gels

A new strategy for the characterization of Coomassie Brilliant Blue stained SDS-PAGE separated proteins by UV-MALDI-MS is reported. The proteins are extracted directly from the polyacrylamide gel by treatment with an organic solvent mixture consisting of formic acid, acetonitrile, isopropanol and water in an ultrasonic bath. A fraction of the supernatant is then mixed directly with the matrix solution and measured by MALDI-MS. High quality spectra could be obtained from gels which were loaded with 6 pmol of myoglobin. Compared to other methods based on electroblotting or electroelution this method is much simpler and less time consuming. The sensitivity is higher than or comparable to the Coomassie Blue staining procedure for proteins up to about 25 kDa. Another advantage is that mass shifts due to charging effects of the membranes, which are common if membranes are mounted directly on the sample target, can be avoided. However, all proteins studied showed slightly higher masses than expected which reduces mass accuracy to 0.2-0.3%. This is presumably partly due to formylation of serine or threonine residues during incubation in formic acid. Gel electrophoresis induced modifications can contribute as well. The possibility of further characterizing the remaining part of the supernatant after extraction by means of proteolytic digestion is also demonstrated. The knowledge of both molecular weight of the whole protein and of the proteolytic fragments increases specificity for protein identification by searching in sequence databases.     

Controlling for a confounder monotonically related to exposure by means of isotonic quantile regression

We present a new approach to evaluating the effect of a continuous exposure factor when that factor increases with a covariate (for example, age) which is regarded as a potential confounder. The basic idea is to estimate, as functions of the covariate, some selected quantiles of the exposure distribution, under the assumption that the dependence of each quantile on the covariate is monotonic. The resulting estimates are then used to divide the data into different exposure categories. This method of categorizing the data implies that the covariate distribution will be almost the same in each exposure group. We illustrate the approach with a study of blood pressure and cardiovascular mortality.     

Oral idarubicin pharmacokinetics--correlation of trough level with idarubicin area under curve

As part of a continuing program aimed at developing nonpolyglutamylatable inhibitors of dihydrofolate reductase that are less toxic and more specific in their action, we herein report the therapeutic efficacy and toxicity of gamma-methylene-10-deazaaminopterin (MDAM) in athymic nude mice bearing advanced human HCT-8 ileocecal xenografts and its antitumor activity in C57BL/6 x DBA/2 F1 (hereafter called B6D2F1) mice bearing P388 murine leukemia. For the xenograft study, MDAM was administered at the maximum tolerated dose by the following dose schedules: (a) 5-day continuous i.v. infusion at 1.0 mg/kg/day (schedule I); and (b) i.v. push, daily for 5 days at 50 mg/kg/day (schedule II). The maximum tolerated dose values for methotrexate (MTX) under these conditions were 0.2 and 1.0 mg/kg/day for schedule I and schedule II, respectively. MTX did not exhibit any significant antitumor activity in this model system by both schedules; however, MDAM induced complete responses of 13 and 25% and partial responses of 25 and 50% by schedules I and II, respectively. MDAM also exhibited antitumor activity significantly superior to that of MTX in the P388 tumor model. One of the enantiomers of MDAM, which possesses the natural configuration at the gamma-methyleneglutamate moiety (l-MDAM), has been shown to be a better inhibitor of human recombinant dihydrofolate reductase and H35 hepatoma cell growth than D,L-MDAM. L-MDAM inhibited the uptake of radiolabeled folinic acid to H35 hepatoma cells eight times more efficiently than MTX. The results indicate that the superior activity of MDAM relative to MTX may be partially due to a combination of enhanced transport to tumor cells and slower deactivation by aldehyde oxidase.     

FLUIDIZED-BED APPARATUS FOR CRYSTAL GROWTH RATE MEASUREMENTS AND ITS TESTING WITH COPPER SULPHATE

Apparatus for measurement of crystal growth rate in a fluidized bed has been modified. The improvement consists of a new way of introducing and removing seeds, which substantially speeds up the measurement and, due to better stability of the temperature regime, leads to improved reliability of results. Growth rates of CuSO₄ · 5H₂O in aqueous solutions, measured in the original and improved apparatus, are compared and they demonstrate the advantages of the new version of the equipment.